China Resources Pharmaceutical Group Limited (HKG:3320)
Hong Kong flag Hong Kong · Delayed Price · Currency is HKD
4.450
-0.080 (-1.77%)
Oct 22, 2026, 4:08 PM HKT

HKG:3320 Financials Overview

Millions CNY. Fiscal year is Jan - Dec.

Revenue & Profits

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
272,165269,574257,673244,704218,183192,920
Revenue Growth
0.96%4.62%5.30%12.16%13.10%14.31%
Gross Profit
44,53244,50840,68938,33733,61928,823
Operating Income
12,25512,65111,98411,0319,7418,019
Net Income
4,1554,0423,3313,8543,5003,070
Earnings Per Share
0.660.640.530.610.560.49
EPS Growth
2.79%21.34%-13.57%10.11%14.00%10.60%

Revenue by Segment

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Distribution
222,745220,080213,237202,153181,418162,222
Others
77.7793.2573.5876.3635.02133.55
Manufacturing
50,67551,03946,32443,46538,03431,458
Retail
13,03312,21010,1049,5797,5886,196
Elimination of Inter-Segment Sales
-14,366-13,848-12,066-10,570-8,891-7,090
Total
272,165269,574257,673244,704218,183192,920

Cash & Debt

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
31,60727,91325,64832,23122,73124,034
Total Debt
78,82372,77069,00562,16156,41655,362
Net Cash (Debt)
-47,215-44,857-43,357-29,930-33,685-31,328
Net Cash Growth
------
Net Cash Per Share
-7.52-7.14-6.90-4.76-5.36-4.99

Cash Flow & CapEx

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
20,36820,47617,53615,55010,82110,462
Capital Expenditures
-2,566-2,331-2,645-2,523-2,279-1,967
Free Cash Flow
17,80218,14614,89113,0278,5428,495
Free Cash Flow Growth
-1.89%21.86%14.31%52.51%0.55%54.34%

Margins

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingJun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
16.36%16.51%15.79%15.67%15.41%14.94%
Operating Margin
4.50%4.69%4.65%4.51%4.46%4.16%
Pretax Margin
4.34%4.38%4.24%4.04%3.83%3.55%
Profit Margin
1.53%1.50%1.29%1.57%1.60%1.59%
FCF Margin
6.54%6.73%5.78%5.32%3.91%4.40%

Dividends

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Dividend Per Share
0.2260.1940.1350.1540.1420.122
Dividend Per Share Growth
77.61%43.70%-12.34%8.81%15.82%20.94%
Dividend Yield
5.09%4.85%2.52%3.31%2.53%4.23%

Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingOct '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PE Ratio
5.836.2210.107.5910.035.92
Forward PE
5.616.577.106.118.755.81
P/FCF Ratio
1.381.392.262.254.112.14
PS Ratio
0.090.090.130.120.160.09